Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations

Frontiers in Pharmacology
2022
José Diogo S. Souza, Maíra Fassoni-Ribeiro, Rayssa Miranda Batista, Juliana Mayumi Ushirohira, Antonio W. Zuardi, Francesco S. Guimarães, Alline C. Campos, Flávia de Lima Osório, Daniel Elias, Cacilda S. Souza, AndRea A. Fassoni, Jaime E. C. Hallak, & José Alexandre S. Crippa

Abstract

Cannabidiol (CBD) is a non-psychotomimetic constituent of the Cannabis plant, with potential therapeutic properties for many physical and neuropsychiatric conditions. Isolated CBD has been suggested to have favorable safety and tolerability. Although CBD-related rash is described, few case reports are well documented in the literature, and usually, CBD was used concomitantly with other medications. Thus, we report four women who presented a skin rash after ongoing CBD use. Other causes of these skin rashes were ruled out after conducting an extensive viral and serological detection panel, and three patients had their lesions biopsied. Two patients were re-exposed to the vehicle (MCT) without developing a new skin rash. Therefore, clinicians must be aware of this potential adverse effect of CBD use.

This library aims to empower you with knowledge but it does not replace the personalized advice and guidance a healthcare professional can provide. Before implementing any changes to your health regimen based on the contents of this library, we strongly advise you to consult with a qualified healthcare professional. Your doctor’s expertise is essential for interpreting how these insights may apply to your unique health circumstances.